Extra-abdominal Removal of Placenta During CS

Summary

During cesarean section, it is important to provide hemostasis as well as to decrease the amount of hemorrhagic fluid and fibrin in the abdominal cavity. Hemorrhagic fluid and fibrin together may cause adhesion formation and therefore postoperative ileus, retardation in regaining the gastrointestinal functions as well as prolongation of the operation itself. Dragging the uterus out of the abdominal cavity during cesarean section before removing the placenta (extra-abdominal removal of the placenta) may decrease the amount of blood flowing into the abdominal cavity during removal of placenta. In this study the investigators aimed to evaluate the influence of intra abdominal vs extra abdominal removal of placenta on duration of operation, the amount of aspirated fluid during the operation, difference between postoperative hemoglobin and hematocrit levels, postoperative pain score, additional need of analgesia, postoperative bowel movements, postoperative endometritis and wound infection.

Conditions

• the Influence of Intra- vs Extra-abdominal Removal of Placenta
• Duration of Operation
• the Amount of Aspirated Fluid During the Operation
• Difference Between Pre- and Post-operative CBC

Interventions

PROCEDURE

Extra-abdominal removal of the placenta

The uterus will be dragged out of the abdominal cavity, prior to removal of the placenta.

PROCEDURE

Extra-abdominal removal of the placenta

The placenta will be manually removed extra-abdominally, with uterine massage as soon as possible.

PROCEDURE

Extra-abdominal removal of the placenta

The cesarean incision will be sutured with no. 1 Vicryl ®.

PROCEDURE

Extra-abdominal removal of the placenta

Uterus will be replaced in the abdominal cavity.

Sponsors & Collaborators

• Near East University, Turkey

  lead OTHER

Principal Investigators

• Baris Kaya, MD · Near East University, Obstetrics and Gynecology, Lefkosa-TRNC, Mersin 10, Turkey

Study Design

Allocation

RANDOMIZED

Purpose

PREVENTION

Masking

NONE

Model

PARALLEL

Eligibility

Min Age

18 Years

Max Age

50 Years

Sex

FEMALE

Healthy Volunteers

Yes

Timeline & Regulatory

Start

2014-03-31

Primary Completion

2014-04-30

Completion

2014-12-31

Countries

• Turkey (Türkiye)

Study Locations